stockfy wrote: The usual suspects a.k.a. "the honest posters" (ROFLMAO) (i.e. besttobe alias etc.) showed up again doing again what they know very well. They twist the truth while also hiding key BULLISH information about VMD. In his desperate effort against VMD, Besttobe alias also promotes other stocks on VMD's board. Meanwhile, VMD is now both technically oversold and grossly undervalued trading 6.5 times its 2021 adj. EBITDA.
For comparison, the vast majority of the names with health care equipment trade well above 10 times their adj. EBITDA. On top of this, the newcomers need to take a look at some of the growth-related excerpts below from the latest CC posted on Seeking Alpha. Both the CEO and the COO are fully confident that VMD will report revenue YoY growth in 2021 for another year in a row while also maintaining a pristine balance sheet, although VMD posted very strong revenue YoY growth in 2020 versus 2019: "The first quarter will very likely be the quarter where things began to reopen from the COVID-19 pandemic and I am once again proud of our ability to keep servicing high need patients. Our new patient uploads during March were the highest single month since the pandemic began and gave us the ability to grow our core business even with the challenges faced during January and February. We are excited to continue utilizing our new programs along with our traditional sales methods as more healthcare systems open around the country.”
and:
"First, let me provide an update on the core business. January and February of 2021 where some of the toughest months we've experienced in Viemed in many years of our core business. We saw the pandemic peaking in January, February, similar to the peak in April and May of 2020. The impact of this kept patients in their homes, reticent to leave the house to address their health care needs. Most physicians were spending the majority of their practice time treating COVID patients in the hospital and most facilities continue to severely limit access to outside companies.
Furthermore, we also literally had to weather the storm, that being the ice storms in the southern region of the country that left many of our patients without power, forcing them back into the hospital to receive care.
Despite these major challenges, we still achieved growth in the quarter of 19% over last year's pre-pandemic and pre-ice storm first quarter. We have expanded our coverage area to 45 states and started up 15 new territories by hiring 15 new reps through April. This execution is on pace to hire 60 new reps during the during 2021, which is the goal at the baseline -- which is the goal that this is the baseline to driving our organic growth. We also expanded our Home Sleep Delivered, sleep apnea business into six new areas, which is another new growth initiatives for 2021."
and:
"Physicians are actively receiving billable codes from our care team and their offices are billing for the monitoring of these patients. As a result of the RPM offering, our physician referral sources have naturally sent more sleep apnea patients our way. We are optimistic about this new trend and will continue to place more HSD reps around the country to expand both RPM and our Home Sleep Delivered model."
and:
"We also added a new feature to engage in the first quarter called clinician, which allows the physician to have a portal where they can remotely tap in and have a real-time look at the care delivered to their patients. The sales force is currently being trained on the features of engage and we expect this to be another strong sales feature that will substantially differentiate us from the competition in 2021."
and:
"Our other new conversation with physicians has been about our behavioral health offering called Viemed Clinical Services. The VCS team has hired and trained licensed clinical social workers in six new areas. Many hospital systems have a strategic focus on helping prepare patients for the end of life, with these conversations being really tough for the physicians to have, our VCS team has proven that we serve as a nice complement for them to carry this conversation forward and give the patient and their family and next level of care. This is going to uniquely differentiate us from the competition. Our behavioral health workers have proven that they can help us retain more patients on vents, contribute to new core business and help drive more hospital partnerships."
and:
"We are actively recruiting to hire these social workers throughout our 45 state coverage area and through this you had another new offering that will help grow and differentiate our core business for years to come. Perhaps the best news of the quarter, is that the most of the growth was captured in the month of March, our busiest months since COVID-19 for new patients. The spread of the vaccine throughout the country has driven patient security and confidence to see their physician's again. This pent-up demand from the patients needing to address their healthcare concerns has led to facilities opening up their doors to home care clinicians with solutions that help free up hospital beds. For the first time in a year, our core business is showing signs that we will soon be growing at our normal pre-pandemic growth rates. We are encouraged by this new trend, especially since we have so many new offerings to review with physicians and patients in the years ahead."
and:
"On the acquisition front, we have been exploring multiple data rooms and learning a lot about several companies that could help springboard our patient growth. We are uncovering many synergies that relates to product mix, payor contracts and further to patient diversification. Our strategy is to look for accretive companies that come with strong human resources to help us carry our Viemed initiative forward faster rate. The companies we are evaluating are medium to large sizes and are in areas that we have a geographic coverage gap. Acquisitions have not been part of our strategy in the past, but with the new regulatory stability and our M&A team in place, we will make acquisitions the meaningful part of our expansion in 2021 and beyond. The regulatory landscape has never been more stable since Mike and I founded the business back in 2006."
and:
"We remain perfectly positioned for rapid growth as we expect to come out of the COVID pandemic over the next few months, in existing and new regions. We have developed a plan of opportunities when it comes to inorganic growth and have begun to build out a team to help evaluate and ultimately integrate down the road. Our mission aligns us with many other respected health care companies and remain confident that we'll find something to augment our historically high organic growth rates."
and:
"The continued trend of servicing patients in the home rather than in hospitals is aligned with our business objective and we anticipate that this trend will continue to offer growth opportunities for us. We expect to continue to be a solution to the rising health costs in the United States by offering more cost effective, home based solutions while increasing the quality of life for patients fighting serious respiratory diseases."